Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior

Stimulants are psychotropic drugs that produce excitation of the central nervous system (CNS). Stimulants have been used in the management of children and adolescents since the 1930s when Dr Charles Bradley first used Benzedrine to treat children with behavioral disturbances (Bradley, 1937).

Adesman, A. R. (2002). New medications for treatment of children with Attention-Deficit/Hyperactivity Disorder: Review and commentary. Pediatric Annals,31, 514-523.PubMedGoogle Scholar

Alto, J. L., & Frankenberger, W. (1994). Effects of methylphenidate on academic achievement from first to second grade. International Journal of Disability, Development and Education,42, 259-273.Google Scholar

American Academy of Child & Adolescent Psychiatry. (2002). Practice parameters for the use of stimulant medication. Journal of the American Academy of Child & Adolescent Psychiatry,41, 1146-1147.Google Scholar

Greenhill, L. L. (2002). Efficacy and safety of OROS MPH in adolescents with ADHD. Presented at 49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Francisco, CA, October 22-27.Google Scholar

Moline, S., & Frankenberger, W. (2001). Use of stimulant medication for treatment of Attention-Deficit/Hyperactivity Disorder: A survey of middle and high school students’ attitudes. Psychology in the Schools,38, 569-584.Google Scholar

MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for children with Attention-Deficit/Hyperactivity Disorder: The multimodal treatment study of children with Attention-Deficit/Hyperactivity Disorder. Archives of General Psychiatry,56, 1088-1096.Google Scholar

MTA Cooperative Group. (2004b). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics,113, 762-769.Google Scholar

Swanson, J. M., Gupta, S., Williams, L., Agler, D., Lerner, M., & Wigal, S. (2002). Efficacy of a new pattern of delivery of methylphenidate in the treatment of ADHD: Effects on activity level in the classroom and on the playground. Journal of the American Academy of Child & Adolescent Psychiatry,41, 1306-1314.Google Scholar

Szymanski, L., & King, B. H. (1999). Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid disorders. Journal of the American Academy of Child and Adolescent Psychiatry,38, 5-31.Google Scholar

Tannock, R., Ickowicz, A., & Schachar, R. (1995a). Differential effects of MPH on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child & Adolescent Psychiatry,34, 886-896.Google Scholar